Michael E Feigin

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Basal Cell Carcinoma

Cell Proliferation

Bioinformatics Analysis

Top Venues

Molecular cancer research : MCR

Genome research

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

Roswell Park Cancer Institute

Stony Brook University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Roswell Park Cancer Institute Jun 30 2017

United States

Assistant Professor :: Pharmacology and Therapeutics

Education History

Stony Brook University

United States

PHD :: Molecular and Cellular Pharmacology

Cornell University

United States

BSC

Publications

Abigail C Cornwell, Arwen A Tisdale, Swati Venkat, Kathryn E Maraszek, Abdulrahman A Alahmari, Anthony George, Kristopher M Attwood, Madison George, Donald Rempinski, Janusz Franco-Barraza, Mukund Seshadri, Mark D Parker, Eduardo Cortes Gomez, Christos Fountzilas, Edna Cukierman, Nina G Steele, Michael E Feigin
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Shamshad Alam, Amanda Zunic, Swati Venkat, Michael E Feigin, Boyko S Atanassov
Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth. Molecular cancer research : MCR 20 (12) (2022)
Miriam Doepner, Inyoung Lee, Christopher A Natale, Roderick Brathwaite, Swati Venkat, Sung Hoon Kim, Yiliang Wei, Christopher R Vakoc, Brian C Capell, John A Katzenellenbogen, Benita S Katzenellenbogen, Michael E Feigin, Todd W Ridky
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling. Science advances 8 (35) (2022)
Swati Venkat, Arwen A Tisdale, Johann R Schwarz, Abdulrahman A Alahmari, Hans Carlo Maurer, Kenneth P Olive, Kevin H Eng, Michael E Feigin
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma. Genome research 30 (3) (2020)